The Brazilian private pharmaceutical market after the first ten years of the generics law.
Andréa Damaso BertoldiAnita K WagnerIsabel Cristina Martins EmmerickLuisa Arueira ChavesPeter StephensDennis Ross-DegnanPublished in: Journal of pharmaceutical policy and practice (2019)
Sales of branded generics and originators decreased substantially in the three therapeutic classes analysed following the introduction of the generics policy in Brazil, but the time to market dominance of generics varied by class.